Nephrocalcinosis and Pseudomonas aeruginosa pyelonephritis; treatment with p-aminomethylbenzene-sulfonamide (sulfamylon).
暂无分享,去创建一个
[1] M. Heideman,et al. The oral and subcutaneous administration ofp-aminomethylbenzenesulfonamide (sulfamylon) , 1948 .
[2] E. L. Knapp,et al. FACTORS INFLUENCING THE URINARY EXCRETION OF CALCIUM. I. IN NORMAL PERSONS. , 1947, The Journal of clinical investigation.
[3] A. D. Welch. Interference with biological processes through the use of analogs of essential metabolites. , 1945, Physiological reviews.
[4] C. A. Lawrence,et al. A Series of New Sulfonamides Which Are Unaffected by p-Aminobenzoic Acid , 1945, Journal of bacteriology.
[5] C. A. Lawrence. In Vitro Studies on the Antibacterial Actions of para-Aminomethylbenzenesulfonamide Derivatives , 1945, Journal of bacteriology.
[6] G. Domagk. Über die Wirkungsweise der Sulfonamide , 1943 .
[7] H. L. Barnett,et al. A STUDY OF SOME OF THE PHYSIOLOGICAL EFFECTS OF SULFANILAMIDE. I. CHANGES IN THE ACID BASE BALANCE. , 1938, The Journal of clinical investigation.